These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 25152025)
1. Microparticles: new light shed on the understanding of venous thromboembolism. Zhou L; Qi XL; Xu MX; Mao Y; Liu ML; Song HM Acta Pharmacol Sin; 2014 Sep; 35(9):1103-10. PubMed ID: 25152025 [TBL] [Abstract][Full Text] [Related]
2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients. Thaler J; Ay C; Pabinger I Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463 [TBL] [Abstract][Full Text] [Related]
4. Of matters great and small. Versteeg HH; Rodger M Thromb Res; 2017 Feb; 150():101. PubMed ID: 28137540 [No Abstract] [Full Text] [Related]
5. Tumour and microparticle tissue factor expression and cancer thrombosis. Date K; Hall J; Greenman J; Maraveyas A; Madden LA Thromb Res; 2013 Feb; 131(2):109-15. PubMed ID: 23237339 [TBL] [Abstract][Full Text] [Related]
6. Microparticles as biomarkers of venous thromboembolic events. Campello E; Spiezia L; Radu CM; Simioni P Biomark Med; 2016 Jul; 10(7):743-55. PubMed ID: 27338783 [TBL] [Abstract][Full Text] [Related]
7. Cancer microvesicles induce tissue factor-related procoagulant activity in endothelial cells in vitro. Adesanya MA; Maraveyas A; Madden LA Blood Coagul Fibrinolysis; 2017 Jul; 28(5):365-372. PubMed ID: 27841803 [TBL] [Abstract][Full Text] [Related]
9. Microparticles and cancer thrombosis in animal models. Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974 [TBL] [Abstract][Full Text] [Related]
10. MP's and VTE's: Fact or fiction. Owens AP; Mackman N Thromb Res; 2011 Dec; 128(6):505-6. PubMed ID: 21945232 [No Abstract] [Full Text] [Related]
11. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Kleinjan A; Böing AN; Sturk A; Nieuwland R Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670 [TBL] [Abstract][Full Text] [Related]
12. Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first trimester. Olausson N; Mobarrez F; Wallen H; Westerlund E; Hovatta O; Henriksson P Thromb Haemost; 2016 Aug; 116(3):517-23. PubMed ID: 27412479 [TBL] [Abstract][Full Text] [Related]
13. Microparticles, thrombosis and cancer. Aharon A; Brenner B Best Pract Res Clin Haematol; 2009 Mar; 22(1):61-9. PubMed ID: 19285273 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Zwicker JI Thromb Res; 2010 Apr; 125 Suppl 2():S89-91. PubMed ID: 20434015 [TBL] [Abstract][Full Text] [Related]
15. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer. Wang M; Huang X; Zhu M; Zhang S; Zhang Y Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323 [TBL] [Abstract][Full Text] [Related]
16. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441 [TBL] [Abstract][Full Text] [Related]